EDNA.life Case Study…at the convergence of Block-Chain and Whole Genome Sequencing.
May 5th, 2021, 4:00 PM – 5:30 PM PDT
**Complimentary to All**
Meeting info provided upon registration
Join the MIT Enterprise Forum of San Diego for a start-up case study right out of 60 Minutes! EDNA.life is a Direct-To-Consumer Genomics company that works at the convergence of Whole Genome Sequencing and Block-Chain technology…with a novel cryptocurrency concept thrown in for good measure! Founder and Technology Entrepreneur, Greg Simpson, will present his vision to enable consumer donors to retain control of their genomic information…either to donate to a cause of their own choosing or being personally compensated for it rather than what may be happening now.
BONUS FEATURE: Greg has agreed to stay on after the formal event for 30 minutes to entertain any general questions from the audience on Block-Chain and cryptocurrency. You know you have them, and you know others have as well! From the very basic to the more complicated, Greg has been involved in block-chain science for greater than 10 years, so you will get a straight answer. Because he is simply that kind of a guy.
Join the MIT Enterprise Forum of San Diego on May 5th at 4:00 PM for what will certainly prove to be an intriguing discussion!
Joseph Carangelo, President and Chapter Chair of the MIT Enterprise Forum of San Diego
Joe Carangelo is the current President and Chapter Chair of the MIT Enterprise Forum of San Diego. His 30-year career has spanned across Management Consulting, Molecular Diagnostics, mobile Health, and most recently Renewable Energy, holding influential roles in Corporate Strategy, Strategic Marketing, and Innovation Business Development at San Diego flagship companies such as Hybritech, Gen-Probe, Great Call, and Baker Home Energy during their high growth and transformative years. He is on the Technology Assessment Committee of the Southern California Energy Innovation Network, where he advises and mentors start-ups through the Program, as well as contributing to Advisory Boards for both private companies and non-profits. Joe has an MBA in Strategy and Innovation from the Stanford University Graduate School of Business, a Master’s degree from the University of California at Berkeley, and a Bachelor of Science in Chemical Engineering from THE Massachusetts Institute of Technology.
Greg Simpson, Founder, EDNA
As a serial entrepreneur and former Senior Principal Engineer at Oracle, Greg’s eclectic career has ranged from nuclear weapon and satellite communication systems though enterprise resource planning software architecture and SWAT-Team leadership for the fortune 100s critical systems. Fast-forward to today where his fascination with the rapidly exploding technologies of both genetics and blockchain provide in his words “… the perfect vehicle to allow us to make a legitimate difference”.
Kimberley Normoyle, Principal, ExecHQ Alliance
Kimberley Normoyle is a registered CPA in Vancouver,Canada with over 11 years of experience in accounting advocacy, inclusive of technology, engineering, and property development, with a special focus on Clean Tech and
Renewable Energy. She supports businesses internationally to add value and improve an organization’s operations by attaining financing through private High Net-Worth and Ultra High Net-Worth Investors and Lenders. Kimberley works with companies at various stages of financin
g starting from Seed Funding and above all while connecting professionals from various businesses with her network of more than 14,000 people and growing. Connect with her on LinkedIn or Instagram to learn more!
Michael Stocum, MS, President and Founder, Personalized Medicine Partners, LLC
Michael is the founding and past chair of the Personalized Medicine Division of the American Association for Clinical Chemistry and has been dedicated to advancing the field of Personalized Medicine. He has also served or is currently serving on several Company Boards and is a frequent guest lecturer on Management, Innovation and Entrepreneurship at NCSU as well as other local universities.
In 2004 Michael founded Personalized Medicine Partners (PMP) to provide global strategic business and operational capabilities for biopharmaceutical, diagnostic and research/clinical services companies, specializing in product development and commercialization of integrated therapeutic and biomarker/companion diagnostic programs. In his industry career, Michael has impacted products across several therapeutic areas, holding corporate roles in pharmaceuticals with GlaxoWellcome/GSK, biologics at Organon (now Merck) and molecular diagnostics at Organon Teknika (now bioMerieux).
Michael has earned dual B.S. degrees in Biochemistry and Microbiology from North Carolina State University (NCSU), with a minor in Genetics and a Masters in Biotech Management.
Visit Our Website to stay updated on future programs.
We look forward to connecting with you,
The Chapter Executive Committee & Advisory Board
MIT Enterprise Forum-San Diego Chapter